WADA’s request for Valieva is unreasonable, Svishchev says

Chairman of the Russian State Duma Committee on Physical Culture and Sports Dmitry Svishchev told he considered the World Anti-Doping Agency’s (WADA) request to remove the Russian figure skater to be unreasonable Kamila Valieva.

On Tuesday, WADA announced that it considered the findings of the Russian Anti-Doping Agency’s (DAK RUSADA) anti-doping disciplinary commission in the Valieva case to be incorrect and appealed to the Court of Arbitration for Sport (CAS). DAK RUSADA has previously concluded that although the athlete committed an anti-doping rule violation, she bears “no fault or negligence”. Valieva escaped penalties other than the voiding of her results as of the December 25, 2021 sample date. of the sampling date.

– RUSADA acts strictly according to its rules and does not violate anything. We recently organized a consultation on the AMA legislation in the direction of hardening. We show our commitment to clean sport. For us, the AMA accusations are strange.

Surprisingly, of course, the AMA requirement. I consider that to be unreasonable. We will fight and defend the interests of our athlete. Only the court and our lawyers can prove Camila’s innocence. If she herself declares that she is not guilty and did not take illegal drugs, the lawyers will find a clear position by which to prove her case. The whole thing can now drag on for at least six months,” Svishchev told .

Valieva at the Beijing Olympics helped the Russian team win gold in team competitions. Before the personal tournament, it became known that the illegal drug trimetazidine was discovered during the doping test of the Russian championship figure skater. The CAS allowed the Russian woman to participate in the individual competitions of the Games, where she took fourth place.

The International Olympic Committee (IOC) has postponed the award ceremony for the team figure skating tournament at the 2022 Games until the end of proceedings in the Valieva case.

Source : MatchTV

Related articles



Please enter your comment!
Please enter your name here

Share article

Latest articles


Subscribe to stay updated.